Device: luminor 14m or angiolite BTK
Number of patients: 50
Type of lesions: long tibial occlusive lesions TASC C and D
luminor DCB is safe and efficacious, in treating highly complex infra-popliteal atherosclerotic lesions in challenging CLTI patients. luminor is associated with highly satisfactory acute technical success, 6-month target lesion patency and AFS.
Presented by Dr Tang (Singapore) at VIVA 2020.